Skip to Content

IRIDEX Corp IRIX

Morningstar Rating
$2.64 −0.05 (1.86%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IRIX is trading at a 42% discount.
Price
$2.63
Fair Value
$4.61
Uncertainty
Extreme
1-Star Price
$71.68
5-Star Price
$2.12
Economic Moat
Jzvz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IRIX is a good fit for your portfolio.

Trading Information

Previous Close Price
$2.69
Day Range
$2.572.69
52-Week Range
$1.313.48
Bid/Ask
$2.64 / $2.66
Market Cap
$42.89 Mil
Volume/Avg
23,518 / 34,347

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.78
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
164

Competitors

Valuation

Metric
IRIX
AFX
Price/Earnings (Normalized)
34.61
Price/Book Value
3.554.81
Price/Sales
0.784.97
Price/Cash Flow
27.59
Price/Earnings
IRIX
AFX

Financial Strength

Metric
IRIX
AFX
Quick Ratio
1.562.41
Current Ratio
2.643.40
Interest Coverage
26.15
Quick Ratio
IRIX
AFX

Profitability

Metric
IRIX
AFX
Return on Assets (Normalized)
−15.91%9.84%
Return on Equity (Normalized)
−41.51%13.77%
Return on Invested Capital (Normalized)
−36.97%12.22%
Return on Assets
IRIX
AFX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesQphmnph$205.8 Bil
SYK
Stryker CorpXbbj$134.3 Bil
MDT
Medtronic PLCYgbk$111.0 Bil
BSX
Boston Scientific CorpWhvyfm$98.5 Bil
EW
Edwards Lifesciences CorpQztcgp$51.2 Bil
DXCM
DexCom IncQfsqz$46.9 Bil
ZBH
Zimmer Biomet Holdings IncDwr$25.4 Bil
ALGN
Align Technology IncLkjgm$23.0 Bil
PHG
Koninklijke Philips NV ADRQqxbjhx$18.4 Bil
PODD
Insulet CorpHmrfxq$11.8 Bil

Sponsor Center